Psilocin

ADVERTISEMENT

Identification

Molecular formula
C12H16N2O
CAS Number
520-53-6
IUPAC Name
3,4,8b-trimethyl-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-7-ol
Molecular Weight
204.27g/mol
Melting Point
(Celsius)
Boiling Point
(Celsius)
Density
1.2200g/cm3
Synonyms
SCHEMBL150459
Interesting facts

Interesting Facts about 3,4,8b-Trimethyl-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-7-ol

This intriguing compound belongs to a class of organic molecules known as indoles, which are characterized by a bicyclic structure that contributes to various biological activities. Here are some fascinating aspects that highlight its significance:

  • Biological Relevance: Compounds with indole structures have been found to exhibit a range of biological activities, including antimicrobial, antifungal, and anticancer properties, making them of great interest in pharmaceutical research.
  • Structural Uniqueness: The presence of the pyrrolo ring fused with the indole ring in this compound adds to the complexity and potential reactivity, making it a subject of synthetic and medicinal chemistry studies.
  • Potential Applications: Researchers are actively exploring the applications of this compound in drug development, particularly in creating novel materials that could lead to innovative therapeutic agents.
  • Synthesis Challenges: The synthetic route to create such a compound is often challenging, involving multiple steps and careful management of reaction conditions to maintain the integrity of the delicate structure.
  • Natural Occurrence: Although this specific compound may not be widely found in nature, related indolic compounds have been identified in various plants and fungi, contributing to their biological activity.

As with many compounds derived from indole, 3,4,8b-trimethyl-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-7-ol shows promise in expanding our understanding of complex chemical interactions, paving the way for enhanced medicinal therapies. The ongoing research into such compounds highlights the vast potential of organic chemistry in addressing critical health challenges.

ADVERTISEMENT